Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19

NCT04360122 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT04360122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04360122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Unknown status
Start date
May 20, 2020
Completion date
December 1, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease (covid-19)